GPC3 and hepatocellular carcinoma: In a report by Ma et al., the cell membrane of CAR T cells was used to construct a membrane-coated nanoplatform with IR 780-loaded mesoporous silica NPs for photothermal therapy.56 CAR-T cells also have the property to target Glypican-3 in hepatocellular carcinoma and thus glypican-3 targeting CAR T cell membrane camouflaged NPs showed enhanced tumor-targeted therapy.